Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Call Transcript 2025

Nov 14, 2025

62142_rns_2025-11-14_bad962da-d074-4ec1-8fcb-a1d2904e76a1.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [205 x 69] intentionally omitted <==

November 14, 2025

BSE Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers Dalal Street Bandra-Kurla Complex Mumbai – 400001 Scrip Code: 524404 Symbol: MARKSANS

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block - G Bandra-Kurla Complex Bandra (East), Mumbai - 400051

Sub: Audio Recording of investor(s) / analyst(s) meet Conference Call on Q2FY26 Financial Results

Dear Sir/Madam,

Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to our letter dated October 31, 2025, we hereby inform the stock exchanges that the Company has uploaded the audio recording of investor(s) / analyst(s) meet conference call on Q2FY26 financial results held today i.e. November 14, 2025 on the Company’s website under the link https://www.marksanspharma.com/earnings-call-transcripts.html

You are requested to note the above in your records.

Thanking You.

Yours faithfully,

For Marksans Pharma Limited

Digitally signed H by H PANIGRAHI PANIGRAHI Date: 2025.11.14 18:50:14 +05'30' Harshavardhan Panigrahi Company Secretary

==> picture [6 x 75] intentionally omitted <==

Marksans Pharma Ltd.

11[th] Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: [email protected]

www.marksanspharma.com